The prevalence and persistence of atopic dermatitis in urban United States children
- PMID: 31128232
- DOI: 10.1016/j.anai.2019.05.014
The prevalence and persistence of atopic dermatitis in urban United States children
Abstract
Background: Previous studies found that childhood atopic dermatitis (AD) and asthma are associated with residence in urban areas. However, little is known about the prevalence and determinants of AD in US urban populations and its impact on quality-of-life (QOL) and asthma.
Objective: To determine AD prevalence and persistence, sociodemographic predictors thereof, and association with QOL and atopic comorbidities in US urban children.
Methods: We analyzed data from The Fragile Families and Child Wellbeing Study, a prospective cohort study of 4898 women and their children born in 20 large US cities between 1998 and 2000. AD prevalence was determined at ages 5, 9, and 15 years, and stratified by sex, race/ethnicity, and household poverty income level.
Results: The prevalences (95% confidence interval [CI]) of childhood AD were 15.0% (11.0%-18.9%), 15.1% (11.5%-18.7%), and 14.5% (10.4%%-18.5%) at ages 5, 9, and 15 years, respectively. Female sex (multivariable repeated measures logistic regression; adjusted odds-ratio [95% CI]: 1.56 [1.02-2.37]) and black race (1.80 [1.07-3.01]) were associated with persistent AD across all 3 ages. Children with AD at ages 5 and 15 (2.63 [1.42-4.86]), 5, 8 and 15 (1.47 [1.02-2.12]) and 9 and 15 years (1.61 [1.00-2.60]) had higher odds of poor/fair/good overall health. Children with AD at ages 5 and 9 years had the highest odds of ever having asthma (adjusted odds ratio [95% confidence interval]: 6.05 [5.88-6.22]), followed by children with AD at ages 5, 9, and 15 years (3.17 [3.07%-3.27]).
Conclusion: Atopic dermatitis prevalence and persistence were highest in US urban children who were female or black. Urban children with persistent AD were more likely to have poor QOL and asthma.
Copyright © 2019 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Rethinking race/ethnicity, income, and childhood asthma: racial/ethnic disparities concentrated among the very poor.Public Health Rep. 2005 Mar-Apr;120(2):109-16. doi: 10.1177/003335490512000203. Public Health Rep. 2005. PMID: 15842111 Free PMC article.
-
Asthma prevalence: a new study challenges conventional wisdom.Am J Nurs. 2015 Apr;115(4):17. doi: 10.1097/01.NAJ.0000463014.83185.94. Am J Nurs. 2015. PMID: 25811509
-
Distribution of atopic dermatitis lesions in United States adults.J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1341-1348. doi: 10.1111/jdv.15574. Epub 2019 Apr 15. J Eur Acad Dermatol Venereol. 2019. PMID: 30883885
-
Epidemiology of atopic dermatitis and atopic march in children.Immunol Allergy Clin North Am. 2010 Aug;30(3):269-80. doi: 10.1016/j.iac.2010.06.003. Immunol Allergy Clin North Am. 2010. PMID: 20670812 Review.
-
African American ancestry contribution to asthma and atopic dermatitis.Ann Allergy Asthma Immunol. 2019 May;122(5):456-462. doi: 10.1016/j.anai.2019.02.009. Epub 2019 Feb 15. Ann Allergy Asthma Immunol. 2019. PMID: 30772392 Free PMC article. Review.
Cited by
-
Reflectance Confocal Microscopy in Monitoring Atopic Dermatitis Treated with Topical Calcineurin Inhibitors.Healthcare (Basel). 2023 Jan 4;11(2):152. doi: 10.3390/healthcare11020152. Healthcare (Basel). 2023. PMID: 36673521 Free PMC article.
-
Antipruritic Effect of Ethyl Acetate Extract from Fructus cnidii in Mice with 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis.Evid Based Complement Alternat Med. 2020 May 6;2020:6981386. doi: 10.1155/2020/6981386. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32454868 Free PMC article.
-
A Comprehensive Systematic Review of Natural Biomedicines for Immune-Mediated and Inflammatory Dermatologic Diseases.Clin Drug Investig. 2025 May;45(5):255-270. doi: 10.1007/s40261-025-01441-y. Epub 2025 Apr 28. Clin Drug Investig. 2025. PMID: 40293693
-
Network pharmacology and molecular docking-based prediction of active compounds and mechanisms of action of Cnidii Fructus in treating atopic dermatitis.BMC Complement Med Ther. 2022 Oct 19;22(1):275. doi: 10.1186/s12906-022-03734-7. BMC Complement Med Ther. 2022. PMID: 36261841 Free PMC article.
-
Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target.Int J Mol Sci. 2022 Mar 23;23(7):3467. doi: 10.3390/ijms23073467. Int J Mol Sci. 2022. PMID: 35408826 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical